Insider Transactions in Q3 2021 at Inmune Bio, Inc. (INMB)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2021
|
Xencor Inc |
BUY
Exercise of conversion of derivative security
|
Direct |
108,000
+5.42%
|
$756,000
$7.8 P/Share
|
|
Aug 25
2021
|
Raymond Joseph Tesi President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+1.93%
|
$90,000
$3.91 P/Share
|
|
Jul 16
2021
|
David J Moss Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+2.0%
|
$75,000
$3.91 P/Share
|
|
Jul 13
2021
|
Timothy J Schroeder Director |
SELL
Open market or private sale
|
Indirect |
14,480
-13.58%
|
$390,960
$27.63 P/Share
|
|
Jul 09
2021
|
Timothy J Schroeder Director |
SELL
Open market or private sale
|
Indirect |
30,000
-21.95%
|
$690,000
$23.2 P/Share
|
|
Jul 08
2021
|
Raymond Joseph Tesi President and CEO |
SELL
Open market or private sale
|
Direct |
24,351
-1.59%
|
$487,020
$20.08 P/Share
|
|
Jul 08
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,302
-1.34%
|
$326,040
$20.09 P/Share
|
|
Jul 08
2021
|
Mark William Lowdell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
24,150
-1.61%
|
$483,000
$20.19 P/Share
|
|
Jul 07
2021
|
Raymond Joseph Tesi President and CEO |
SELL
Open market or private sale
|
Direct |
5,649
-0.37%
|
$112,980
$20.02 P/Share
|
|
Jul 07
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,698
-0.71%
|
$173,960
$20.01 P/Share
|
|
Jul 07
2021
|
Mark William Lowdell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,850
-0.39%
|
$117,000
$20.02 P/Share
|